Literature DB >> 21642669

Retinoblastoma therapy delivers power of chemotherapy with surgical precision.

M J Friedrich.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21642669     DOI： 10.1001/jama.2011.778

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  4 in total

Review 1.  Retinoblastoma frontiers with intravenous, intra-arterial, periocular, and intravitreal chemotherapy.

Authors:  C L Shields; E M Fulco; J D Arias; C Alarcon; M Pellegrini; P Rishi; S Kaliki; C G Bianciotto; J A Shields
Journal:  Eye (Lond)       Date:  2012-09-21       Impact factor: 3.775

2.  Safety and efficacy of posterior sub-Tenon's carboplatin injection versus intravitreal melphalan therapy in the management of retinoblastoma with secondary vitreous seeds.

Authors:  Azza Mohamed Ahmed Said; Mohamed Gamil Aly; Hazem Omar Rashed; Anwaar Mahmoud Rady
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

3.  A temperature-sensitive phase-change hydrogel of topotecan achieves a long-term sustained antitumor effect on retinoblastoma cells.

Authors:  Yan Huo; Qun Wang; Ying Liu; Junyi Wang; Qian Li; Zongyuan Li; Yan Dong; Yifei Huang; Liqiang Wang
Journal:  Onco Targets Ther       Date:  2019-07-30       Impact factor: 4.147

4.  Detection of leukocoria using a soft fusion of expert classifiers under non-clinical settings.

Authors:  Pablo Rivas-Perea; Erich Baker; Greg Hamerly; Bryan F Shaw
Journal:  BMC Ophthalmol       Date:  2014-09-09       Impact factor: 2.209
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.